ALZN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alzamend Neuro Inc (ALZN) is not a strong buy at this moment for a beginner investor with a long-term strategy. Despite the recent insider purchase and a positive short-term price movement, the company's weak financial performance, lack of significant trading trends, and absence of strong technical or proprietary trading signals suggest that it is better to hold off on investing in this stock for now.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 60.723, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level (R1: 1.17), which may limit further upside in the short term.
Insider purchase by Milton C. Ault III, which led to an 11% price increase. Insider purchases are often seen as positive signals for a company's future performance.
Weak financial performance with no revenue growth, a significant net loss (-$2,198,991), and a sharp decline in EPS (-66.86% YoY). No significant trading trends from hedge funds or insiders. Stock trend analysis suggests a potential decline in the next week and month.
In Q3 2026, the company reported no revenue growth (0% YoY), a net loss of -$2,198,991 (up 104.91% YoY), and a sharp decline in EPS to -0.58 (-66.86% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance.
No analyst rating data or price target changes available.
